16th-18th September 2009, Geneva
In September 2008, leading biotech CEOs and top pharma representatives met to network, discuss industry change and do the deals which will ensure success in 2009. With presentations from Wyeth, Novartis, Roche, Pfizer, Lilly, Boehringer, AstraZeneca, Merck, GSK and many others, delegates got true insight into the deals which have shaped 2008.
Once again, BioBusiness Network proved essential to delegates as a forum for personal and informal networking. No other conference offers the same high level of seniority and intimacy as BioBusiness Network, resulting in delegates having the time and the opportunity to meet with their partners of choice in a relaxed and unhurried setting. For your chance to meet with the industry’s most powerful decision makers, make sure you sign up for BioBusiness 2009! |